142 related articles for article (PubMed ID: 37354045)
1. Nutritional therapy for persistent cognitive impairment after resolution of overt hepatic encephalopathy in patients with cirrhosis: A double-blind randomized controlled trial.
Sharma BC; Maharshi S; Sachdeva S; Mahajan B; Sharma A; Bara S; Srivastava S; Kumar A; Dalal A; Sonika U
J Gastroenterol Hepatol; 2023 Nov; 38(11):1917-1925. PubMed ID: 37354045
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial.
Maharshi S; Sharma BC; Sachdeva S; Srivastava S; Sharma P
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):454-460.e3; quiz e33. PubMed ID: 26453952
[TBL] [Abstract][Full Text] [Related]
3. A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study.
Fagan A; Gavis EA; Gallagher ML; Mousel T; Davis B; Puri P; Sterling RK; Luketic VA; Lee H; Matherly SC; Sanyal AJ; Stravitz RT; Patel V; Siddiqui MS; Asgharpour A; Fuchs M; Thacker L; Bajaj JS
J Hepatol; 2023 Feb; 78(2):312-321. PubMed ID: 36152764
[TBL] [Abstract][Full Text] [Related]
4. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
[TBL] [Abstract][Full Text] [Related]
5. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
[TBL] [Abstract][Full Text] [Related]
6. Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China.
Li SW; Wang K; Yu YQ; Wang HB; Li YH; Xu JM
World J Gastroenterol; 2013 Dec; 19(46):8745-51. PubMed ID: 24379595
[TBL] [Abstract][Full Text] [Related]
7. Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis.
Bajaj JS; Duarte-Rojo A; Xie JJ; Acharya C; Wade JB; Robles C; Thacker LR; Flud C; Fagan A; Garcia-Saenz-de-Sicilia M; White MB; Kelly M; Nguyen V; Gavis EA; Vargas HE
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3008-3016.e2. PubMed ID: 32205222
[TBL] [Abstract][Full Text] [Related]
8. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
Mittal VV; Sharma BC; Sharma P; Sarin SK
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
[TBL] [Abstract][Full Text] [Related]
10. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial).
Sidhu SS; Goyal O; Mishra BP; Sood A; Chhina RS; Soni RK
Am J Gastroenterol; 2011 Feb; 106(2):307-16. PubMed ID: 21157444
[TBL] [Abstract][Full Text] [Related]
11. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests.
Felipo V; Urios A; Giménez-Garzó C; Cauli O; Andrés-Costa MJ; González O; Serra MA; Sánchez-González J; Aliaga R; Giner-Durán R; Belloch V; Montoliu C
World J Gastroenterol; 2014 Sep; 20(33):11815-25. PubMed ID: 25206287
[TBL] [Abstract][Full Text] [Related]
12. Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy.
Espina S; Gonzalez-Irazabal Y; Sanz-Paris A; Lopez-Yus M; Garcia-Sobreviela MP; Del Moral-Bergos R; Garcia-Rodriguez B; Fuentes-Olmo J; Bernal-Monterde V; Arbones-Mainar JM
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836020
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of minimal hepatic encephalopathy in cirrhotic patients.
Maldonado-Garza HJ; Vázquez-Elizondo G; Gaytán-Torres JO; Flores-Rendón AR; Cárdenas-Sandoval MG; Bosques-Padilla FJ
Ann Hepatol; 2011 Jun; 10 Suppl 2():S40-4. PubMed ID: 22228880
[TBL] [Abstract][Full Text] [Related]
14. Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy.
Duarte-Rojo A; Estradas J; Hernández-Ramos R; Ponce-de-León S; Córdoba J; Torre A
Dig Dis Sci; 2011 Oct; 56(10):3014-23. PubMed ID: 21461913
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).
Badea MA; Drug VL; Dranga M; Gavrilescu O; Stefanescu G; Popa I; Mihai C; Cijevschi-Prelipcean C
Metab Brain Dis; 2016 Dec; 31(6):1463-1471. PubMed ID: 27461111
[TBL] [Abstract][Full Text] [Related]
16. Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy.
Stawicka A; Jaroszewicz J; Zbrzeźniak J; Sołowianowicz N; Woszczenko A; Świderska M; Flisiak R
Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32455895
[No Abstract] [Full Text] [Related]
17. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Ferrandez A; Rodrigo JM; Felipo V
J Mol Med (Berl); 2007 Mar; 85(3):237-45. PubMed ID: 17216205
[TBL] [Abstract][Full Text] [Related]
18. [Minimal hepatic encephalopathy: a better diagnostic to improve prognostic].
Ennaifer R; Cheikh M; Hefaiedh R; Romdhane H; Ben Nejma H; Hadj NB
Presse Med; 2014 May; 43(5):e127-33. PubMed ID: 24703736
[TBL] [Abstract][Full Text] [Related]
19. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
20. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.
Sidhu SS; Goyal O; Parker RA; Kishore H; Sood A
Liver Int; 2016 Mar; 36(3):378-85. PubMed ID: 26201713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
